Market revenue in 2023 | USD 23.6 million |
Market revenue in 2030 | USD 150.8 million |
Growth rate | 30.3% (CAGR from 2023 to 2030) |
Largest segment | Kits & reagents |
Fastest growing segment | Kits & Reagents |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Kits & Reagents, Instruments, Services |
Key market players worldwide | Danaher Corp, Hologic Inc, FUJIFILM Holdings Corp, Lonza Group Ltd, Miltenyi Biotec, Bio-Techne Corp, Qiagen NV, Thermo Fisher Scientific Inc, Abcam PLC, RoosterBio |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to exosomes market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 45.34% in 2023. Horizon Databook has segmented the Asia Pacific exosomes market based on kits & reagents, instruments, services covering the revenue growth of each sub-segment from 2018 to 2030.
The region is expected to exhibit lucrative growth owing increase in awareness about innovative and novel technologies. Increase in focus on the development of healthcare infrastructure along with the demand for advanced diagnostics & efficient therapeutic solutions are among factors expected to positively influence growth.
Furthermore, emerging economies in the region are involved in establishing research facilities and infrastructure for the emerging biotechnology field. Human resource with the required skills is available on a large scale. Leading market players are involved in collaborations and partnerships to tap the growth potential in these regions.
For instance, in November 2013, Agilent Technologies, Inc. collaborated with Seoul National University Hospital for the development of biomarkers. Japan dominated the APAC market in 2018. High incidence of degenerative disorders owing to the presence of a large aging population and the rapid adoption of technologically advanced products are among significant factors contributing to the country largest market share.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific exosomes market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific exosomes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account